Heron Therapeutics, Inc. announced changes to its commercial leadership team, including the appointment of Jason Grillot as Vice President, Sales and Marketing, Acute Care, effective April 24, 2023. Mr. Grillot brings more than two decades of hospital experience, most recently serving as a senior sales executive at CHIESI USA. In addition, John Poyhonen, Heron's President and Chief Commercial Officer, and Michael Mathews, Heron's Senior Vice President Commercial, Acute Care, will cease to serve in their positions as of April 30, 2023.

Following the departures of Mr. Poyhonen and Mr. Mathews, Craig Collard, Heron's Chief Executive Officer, will oversee Heron's commercial organization.